The LIMD1-MYBL1 index as a composite marker for subtype classification and survival prediction for diffuse large B-cell lymphoma patients.
Qinghua Xu(Anhui Academy of Medical Sciences), Du Xiang(Fudan University), Xia Meng(Qilu University of Technology), Xun Ye(Capital Medical University), Fang Liu(Aichi Cancer Center), Fei Wu(Fudan University Shanghai Cancer Center), Shujuan Ni(Shanghai Medical College of Fudan University), Cong Tan(Shanghai Medical College of Fudan University), Weiqi Sheng(Shanghai Medical College of Fudan University)
Cited by 0
Related Papers
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
|International Journal of Cancer|2009|979
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
|Journal of Hematology & Oncology|2018|371
Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer
|Cancer Epidemiology Biomarkers & Prevention|2016|248